Travis Matthiesen
Analyst · Credit Suisse. Your line is open
Thanks, Clint, and good afternoon, everyone. I also want to start by thanking our teams for their hard work over the past year. Turning to Slide 12, you’ll see the key financial highlights for both the year and the quarter. Starting with the fourth quarter, total revenue grew 1% to $450 million, fueled by Medicare Advantage commissionable approved submissions of 654,000, growth of 99%. This policy growth was offset by a fourth quarter lookback totaling $155 million relating to Medicare Advantage policies sold in prior periods. Fourth quarter adjusted EBITDA totaled $2 million, down from $170 million in the prior year period. Again, this was mainly driven by the lookback taken in the current quarter relating to prior period policies. We will walk through that in greater detail later on in the call. Moving to full year 2021 results. Revenue increased 21% year-over-year, growing to $1.062 billion. Excluding the lookback from prior periods, revenue grew 40% to $1.227 billion. Medicare Advantage submissions grew 60% for the full year, totaling roughly 1.2 million submissions in 2021. Finally, adjusted EBITDA for the full year was $34 million and $146 million prior to the lookback. Slide 13 better illustrates the growth we’ve seen during the last few fourth quarters and AEP periods. As you can see on the far right side of the slide, when removing the lookback adjustment, the fourth quarter saw a 35% increase in revenue growth. This increase was driven by a 94% increase in Medicare Advantage submissions and offset by a 25% decrease in LTVs relative to last year’s reported MA LTVs, inclusive of a 15% constraint that was applied on top of previously modeled constraints. A lot has been said about the market dynamics in our sector regarding lookbacks, policy churn and ultimately reported LTVs, so I wanted to spend some more time over the next few slides detailing what we are seeing in our space today and what we expect to see moving forward. Starting with Slide 14, you’ll see details surrounding the lookback. Before we dive into the numbers, I wanted to first provide some context. We engaged a third-party actuarial firm to analyze our models and help us validate LTVs given the acceleration in churn we are seeing with our historic policy vintages. Through that process, we concluded that we would be best served taking a lookback adjustment totaling $155 million in the fourth quarter, relating to Medicare Advantage policies sold as far back as 2018. To put that adjustment in perspective, the total revenue originally recognized for those vintages is roughly $1.5 billion. Since inception, we have taken smaller look back adjustments relating to these vintages but the acceleration observed in the last six months drove the $155 million taken in Q4. So to put that $155 million in context, it represents a roughly 11% downward adjustment to the originally recognized $1.5 billion in revenue. It’s also important to note that 42% of or $636 million of the recognized $1.5 billion in revenue has been collected thus far across all those vintages impacted. We are, of course, disappointed with the trends we have seen with our historic vintages, but we are making the necessary investments and changes to our marketing, sales and TeleCare teams and processes to improve policy retention moving forward. Moving to Slide 15, the second biggest driver of fourth quarter results being lower than our projections is the additional 15% constraint we’ve applied to our Medicare Advantage policies sold in the quarter. As you can see from the bar chart shown on the slide, reported fourth quarter LTVs are 25% lower than prior year reported LTVs. When adjusting the Q4 2020 LTVs for the impact of the look back adjustment, Q4 2021 LTVs are in line with prior year. And after accounting for the impact of the look back adjustments on those prior vintages, a 15% decrease. This is driven by a few main factors. First, the combination of observed macro shopping trends, plan mix and new agent performance during Q4 were all drags on LTVs. As Clint mentioned, while we hit our agent hiring targets for the fourth quarter, we have the highest percentage of new agents on the phone this past AEP as compared to prior AEPs. The combination of all the aforementioned items ultimately drove lower-than-anticipated effectuation rates, which were offset by higher carrier commissions and expanded Encompass revenue. Second, given the acceleration and churn we have seen in prior vintages, we also elected to apply an additional 15% constraint on calculated LTVs here in the fourth quarter. Again, it’s important to note that this is applied on top of prior constraints embedded in our model. Slide 16 provides some color on the components of our revenue growth in the quarter. Commission growth continues to increase as illustrated by the $24 million increase in commission revenue post-look back and $179 million increased pre-look back, a 36% increase. Medicare-Internal continues to power our growth, a 5% increase in the fourth quarter, inclusive of the look back adjustment. Our External Medicare channel continues to be important to our business. As a reminder, our external programs are yet another way for us to drive quality membership growth as small and midsized agencies right policies under a revenue share arrangement where they are paid only when we are paid. These agents are not outsourced BPO programs, rather they utilize our technology, compliance and carrier contracts to write quality business for carriers. And finally, we have our ISP business with revenue of 48% as we continue to reallocate towards the faster-growing and higher-margin Medicare business. The top line drag from IFP lessons going forward as IFP’s share of total company revenue continues to diminish. Let’s now move to Slide 17. Fourth quarter adjusted EBITDA of $2 million post-look back was well below our expectations, and we are taking the measures necessary here in 2022 to improve upon these levels. Continued strong consumer response to our marketing combined with demand from our carrier partners, is still indicative of a healthy fast-growing market. And we believe the strength of our marketing capabilities, agent investments an integrated business model developed over the last 20 years, will continue to expand our leadership in this space. But we need to slow down to improve our execution and adjust to the recent trends in consumer behavior. We have the plans and motion to deliver on that in 2022, and I’ll come back to that in a minute. But first, let me quickly summarize our full year 2021 results shown on Slide 18. Full year revenue of $1.062 billion was an increase of 21% on top of the prior year’s 63% growth. EBITDA of $34 million declined 88% relative to prior year’s results. While we are not pleased with these results, they nonetheless stand in stark contrast to those reported by some of our competitors and validate our superior tech-enabled agent strategy. The investments we’ve made in scale coupled with the expansion of our Encompass platform will help drive revenue per submission higher in future periods. Moving on to cash flow shown on Slide 19. We exited 2021 with $84 million of cash on hand and access to $45 million of untapped revolver. We collected a record level of cash during the year, which we reinvested into building a larger book of future commission streams manifesting in roughly $300 million of commission collections thus far here in Q1. So while we have grown our submission count dramatically over the last few years, in 2022, we are moving towards a more deliberate growth strategy funded by our current cash balance, access to the revolver and cash generated from previously sold policies. Slide 20 showcases our growing commissions receivables balance. Put simply, it’s the largest absolute and percentage growth in the industry. During fiscal 2021, we grew our commissions receivables balance by 56% to $1.3 billion, inclusive of the look back previously discussed. And we collected $428 million in cash, a year-over-year increase of 75%. Year-over-year cash collected from commissions is another metric to illustrate our continued growth in size and the important part we play in the Medicare Advantage ecosystem. Starting with Slide 21. I’ll spend the next few minutes diving into a bit more detail on 2022 guidance before turning the call over to Clint to walk through our strategic initiatives. So with that, let me now move on to the 2022 outlook shown on Slide 22. We expect to deliver full year revenue of $900 million to $1.1 billion, representing a range of growth between negative 15% and positive 4%. This will be driven by continuing our focus on Medicare Advantage enrollments and the expansion of our Encompass platform. From an adjusted EBITDA perspective, we plan to deliver $110 million to $150 million, representing growth between 224% and 343%. As a reminder, that growth is outsized given the look back we took in Q4. Finally, we expect cash flow from operations of negative $50 million to negative $10 million for the current year and given the seasonal nature of our business being cash flow positive from operations on a trailing 12-month basis in the first half of 2023. Moving to Slide 23, you can see revenue guidance. As mentioned earlier, we continue to focus on our Medicare channel, and we’ll have a particular emphasis on the quality of our enrollments. This includes a decrease of 9% commissionable revenue growth at the midpoint, while we slowed down our enrollments. We also expect roughly flat enterprise revenue as we continue to expand our programs across more carriers, but offset by lower submission growth in the current year. We expect short-term year-over-year decreases in our LTVs in quarters one through three, given the additional constraint we are applying. Once we arrive in Q4 where LTVs would be more comparable, we expect LTVs to be flat year-over-year. Upside would result from our efforts to drive higher persistency and increased penetration of Encompass members. Regarding enterprise revenue, we have built in prudent assumptions on enterprise revenue despite the encouraging conversations we are having with carriers about expanding our partnerships, be it marketing services, technology or Encompass programs. We expect enterprise revenue to be roughly flat this year or roughly 20% of revenue compared to enterprise at 17% of total revenue this past year. Finally, we expect modest growth from our external Medicare business as carriers increasingly push agencies to work with us on our platform and continued declines in our IFP business. Moving on to Slide 24. We expect 2022 adjusted EBITDA to come in between $110 million to $150 million, representing growth of 282% and margins of 13% at the midpoint. As Clint mentioned earlier, we have learned from both the operational missteps made in 2021 and the changing market dynamics and are reacting accordingly through slowing down growth and focusing on the incremental margin of the next sale made. The combination of our reduction in agent hiring, more focused marketing and reductions made in our corporate cost structure will be key drivers in the improved profitability in 2022. To help you better model the impact and timing of these initiatives in 2022, we expect lower absolute EBITDA and revenue during the first nine months of the year as we pivot to a more optimized agent force combined with lower reported LTVs. The execution of these efforts will allow us to capitalize on the most important quarter, the fourth quarter, building momentum into 2023. As we move into the annual enrollment period in the fourth quarter, we anticipate continued margin gains powered by our optimization efforts driving improvements in both marketing efficiencies and agent performance. We won’t need an increase in qualified leads to hit our numbers focusing on higher quality enrollments and upsized Encompass programs to both drive down CPAs and increase revenue per submission. Finally, we are prioritizing improving cash flow from operations. You can see on Slide 25, how we plan on executing on our cash flow strategy. First, based on our historic rapid growth, we will walk into 2022 with meaningfully higher commission collections as compared to prior years, driven by the strength of the policies sold in 2021 and prior periods. Second, we continued to expand our Encompass programs across multiple carriers, which will drive more cash into the business in the current year. Third, we will be much more selective in our marketing channels, focusing on higher-quality members. That will be combined with slowing down the hiring of new agents and leveraging our more tenured agents in the current year as we move to a more optimized model. As mentioned earlier, we have laid out a plan that achieves two main objectives: first, executing on the goal of maintaining our market position by driving high-quality volume for our carrier partners; and second, maintaining this position while simultaneously being the fastest to cash flow breakeven with the goal on a trailing 12-month basis of being cash flow positive from operations by the first half of 2023. Finally, Slide 26 illustrates the power of our previously sold policies and the cash we expect to generate in 2022. These previously written policies and cash flows combined with policies sold in 2022, and we expect to have a more favorable year one cash profile due to our Encompass traction will generate more cash per policy sold in 2022 than any prior period. That, in combination with the cost strategies we have discussed gives us confidence in our ability to meaningfully improve our cash position and positions us well for future growth. So in summary, we’ve maintained our position as a leader in our space and have identified the investment areas that positions us well for 2022 and sets the stage for us to deliver compounding growth over the coming years. With that, let me now turn the call back over to Clint for some closing remarks. Clint?